Transplantation of bone marrow derived macrophages reduces markers of neuropathology in an APP/PS1 mouse model
Open Access
- 14 October 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in Translational Neurodegeneration
- Vol. 8 (1), 1-11
- https://doi.org/10.1186/s40035-019-0173-9
Abstract
We investigated early hallmarks of putative therapeutic effects following systemic transplantation of bone marrow derived macrophages (BM-M) in APP/PS1 transgenic mice. BM-M were transplanted into the tail vein and the animals analysed 1 month later. BM-M transplantation promoted the reduction of the amyloid beta [37-42] plaque number and size in the cortex and hippocampus of the treated mice, but no change in the more heavily modified pyroglutamate amyloid beta E3 plaques. The number of phenotypically ‘small’ microglia increased in the hippocampus. Astrocyte size decreased overall, indicating a reduction of activated astrocytes. Gene expression of interleukin 6 and 10, interferon-gamma, and prostaglandin E receptor 2 was significantly lower in the hippocampus, while interleukin 10 expression was elevated in the cortex of the treated mice. BM-M systemically transplanted, promote a decrease in neuroinflammation and a limited reversion of amyloid pathology. This exploratory study may support the potential of BM-M or microglia-like cell therapy and further illuminates the mechanisms of action associated with such transplants.Keywords
Funding Information
- Engineering and Physical Sciences Research Council
- Fraunhofer-Institut für Zelltherapie und Immunologie
This publication has 34 references indexed in Scilit:
- Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegenerationSeminars in Immunopathology, 2013
- Functional Impairment of Microglia Coincides with Beta-Amyloid Deposition in Mice with Alzheimer-Like PathologyPLOS ONE, 2013
- Intracellular accumulation of aggregated pyroglutamate amyloid beta: convergence of aging and Aβ pathology at the lysosomeAGE, 2012
- A Review: Inflammatory Process in Alzheimer's Disease, Role of CytokinesThe Scientific World Journal, 2012
- Pyroglutamate-Aβ 3 and 11 colocalize in amyloid plaques in Alzheimer's disease cerebral cortex with pyroglutamate-Aβ 11 forming the central coreNeuroscience Letters, 2011
- Pyroglutamate Amyloid-β (Aβ): A Hatchet Man in Alzheimer DiseaseOnline Journal of Public Health Informatics, 2011
- Differentiation of mouse bone marrow derived stem cells toward microglia-like cellsBMC Cell Biology, 2011
- Multicolor time-stamp reveals the dynamics and toxicity of amyloid depositionScientific Reports, 2011
- Intraneuronal pyroglutamate-Abeta 3–42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse modelActa Neuropathologica, 2009
- Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathologyEMBO Reports, 2006